Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-04

Clinical Trial Update: Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intranasal calcitonin for analgesia in rib fracture patients; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcitonin-salmon, intranasal (calcitonin-salmon)

Snippet

Sponsor: Université de Montréal | Conditions: Rib Fractures, Pain | Phase 4 | Status: TERMINATED